XSHE
000503
Market cap1.15bUSD
Oct 09, Last price
8.43CNY
1D
6.84%
1Q
31.72%
Jan 2017
-79.95%
Name
China Reform Health Management and Services Group Co Ltd
Chart & performance
P/E
—
P/S
23.56
EPS
—
Div yield, %
—
Shrs. gr., 5y
1.73%
Rev. gr., 5y
11.06%
Revenues
350m
-1.81%
Net income
-404m
L+3,793.75%
CFO
-82m
L-1.01%
Dividend
May 31, 20040.1 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
China Reform Health Management and Services Group Co., Ltd. offers medical insurance management services in China. It provides services of medical insurance funds, medical quality and safety, drug and device supervision, and internet health protection. It is also involved in the pharmaceutical and medical business. China Reform Health Management and Services Group Co., Ltd. was formerly known as SeaRainbow Holding Corp. and changed its name to China Reform Health Management and Services Group Co., Ltd. in May 2018. The company was founded in 1987 and is based in Beijing, China.
Key people
Wenchang Wang
Chief Accounting Officer · since 2022
Wei Zhou
General Counsel, Deputy General Manager · since 2025
Zhenhua Zhang
Deputy General Manager · since 2025
Xinxing Liu
Secretary of the Board · since 2021
Tao Chen
Director · since 2022
Kaihong Jiang
Director · since 2018
Yonghua Li
Chairman of the Board · since 2024
Yingjie Liu
Deputy General Manager, Director · since 2018
Min Song
Director · since 2025
Director · since 2025
Hongquan Yuan
General Manager, Director · since 2024
Yan Bai
Independent Director · since 2022
Na Sun
Independent Director · since 2024
Jie Sun
Independent Director · since 2022
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||